image: Genetic Engineering & Biotechnology News is published in print and online 21 times a year by Mary Ann Liebert, Inc., publishers. view more
Credit: © Mary Ann Liebert, Inc., publishers, 2010
New Rochelle, NY, August 13, 2010—Scientists are turning to a decades-old technique to better understand the physical effects of compression on macromolecules and how it might impact their research in proteomics, mass spectrometry, protein extraction, and tissue investigations, reports Genetic Engineering & Biotechnology News (GEN). These studies are built upon the early ultrahigh pressure discoveries of the late Nobel Prize winner in Physics, Percy Bridgman, Ph.D., who was a professor at Harvard from 1908 to 1954, according to the August issue of GEN (http://www.genengnews.com/gen-articles/use-of-ultrahigh-pressure-on-the-rise/3360).
"Pressure-cycling technology (PCT) has definitely caught the attention of an increasing number of scientists," says John Sterling, Editor in Chief of GEN. "In addition, researchers no longer need to construct their own tools because instruments such as the Barocycler® from Pressure Biosciences are now available."
Zoltan Szabo, Ph.D., senior research scientist at the Barnett Institute at Northeastern University, relies on PCT for glycan analysis. Glycans are ordinarily N-linked and are evaluated using capillary electrophoresis and liquid chromatography. Dr. Szabo and his colleagues, however, used PCT to accelerate N-linked glycan release by peptides using the enzyme N-Glycosidase F, also known as PNGase F.
Membrane proteins represent one of the most appealing targets for cancer detection and therapy. But the extraction of proteins from membranes is complex and challenging, given the inculcation of the proteins throughout a tenacious lipid bilayer. For this reason, Luke Schneider, Ph.D., CSO, Target Discovery, and his co-workers have applied PCT to the extraction of membrane proteins from ovarian cancer tissues.
Other studies covered in the GEN article include research at the Armed Forces Institute of Pathology, University of Missouri, the FDA's CBER, and the Pacific Northwest National Laboratory.
For a copy of the August issue of GEN, please call (914) 740-2122, or email: ebicovny@liebertpub.com
Genetic Engineering & Biotechnology News (www.genengnews.com), which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.
Journal
Genetic Engineering & Biotechnology News